Decline in the use of opioids and psychotropics in patients treated with new CF therapies

The Centre for Medicine Use and Safety within the Monash Institute of Pharmaceutical Sciences has released research that shows a decline in the use of opioid and psychotropic medicines following the reimbursement of ‘modulator therapy’ for cystic fibrosis. …